Risk of dying from incurable prostate cancer drops by nearly a quarter in seven years, major NHS study finds

From the Newshound archive · first published 8 October 2026 · last updated 9 October 2026.

Men with advanced, incurable prostate cancer in England are surviving longer, with the proportion dying within three years dropping from 56% in 2015 to 47% in 2022. The findings come from a London School of Hygiene & Tropical Medicine analysis of 45,339 men diagnosed with metastatic prostate cancer between 2015 and 2022. New NHS treatments, including triplet therapy — combining three drugs at once — are credited with driving the improvement.

Prostate cancer diagnoses in England rose 7% in a single year to 60,800 in 2026, with over 6,300 cases now classed as metastatic.